Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,264 | 26,629 | 41,505 | 43,874 | 46,938 |
| Receivables | 1,086 | 980 | 936 | 820 | 12,120 |
| TOTAL | $26,453 | $27,764 | $42,691 | $44,768 | $59,581 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 146 | 284 | 354 | 505 | 589 |
| TOTAL | $146 | $284 | $354 | $505 | $589 |
| Total Assets | $26,599 | $28,048 | $43,045 | $45,273 | $60,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 433 | 561 | 607 | 2,134 | 5,146 |
| TOTAL | $451 | $580 | $874 | $3,726 | $13,347 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 121 | 52 | 46 | 34 | 71 |
| TOTAL | $121 | $52 | $46 | $34 | $71 |
| Total Liabilities | $572 | $632 | $920 | $3,760 | $13,418 |
| Shareholders' Equity | |||||
| Common Shares | 21,304 | 22,150 | 18,398 | 18,117 | 19,786 |
| Retained earnings | 4,207 | 4,740 | 7,636 | 7,554 | 9,665 |
| Other shareholders' equity | 8 | 0 | 0 | 0 | 0 |
| TOTAL | $26,027 | $27,416 | $42,125 | $41,513 | $46,752 |
| Total Liabilities And Equity | $26,599 | $28,048 | $43,045 | $45,273 | $60,170 |